Second Quarter Business Results for Fiscal 2019 (From April 1, 2019 to September 30, 2019)

from the beginning

Second Quarter Business Results for Fiscal 2019

• 2Q Consolidated Performance for Fiscal 2019

• Key Points in Performance

• Factors for changes in Operating Profit

• Financial Condition / Cash Flow Position

• Roadmap to Realizing Our Long-Term Vision

• Sales performance of prescription Kampo products

• Sales Strategy for Daikenchuto -1

• Sales Strategy for Daikenchuto -2

• Sales Strategy for Rikkunshito

• Sales Strategy for Yokukansan

• Approaches in the Kampo Medicine Seminar

• Approaches to “doctors prescribing 10 or more Kampo products”

• Key Sales Measures in the 2nd Half of the Year

FY2019 Performance Forecasts

• FY2019 Performance Forecasts

Return of Profits to Shareholders

• Return of Profits to Shareholders

@

Growth Investment in China & Building Business Foundations

• China Business Vision

• All Tsumura Directors Visited China (Sep 2019)

• China Business: Progress Report

• Diagram of Capital Ties/Sales Routes in China Business

• Build a Crude Drug Platform

• Conclusion of Letter of Intent for Capital Alliance with Tianjin China Medico Technology

• Build crude drug platform & sales system

• Pingcun Medicine Sales Channels (current)

• China Business: NEXT Stage

Integrated Report 2019

• Sustainability Vision

• Key Points in the Integrated Report 2019

@